TNFRSF8-eiwit (C-His, mens)

TNFRSF8

CD30, D1S166E, Ki-1

C-His

< 1.0 EU per μg protein as determined by the LAL method.

≥ 90 % as determined by SDS-PAGE.

1.Flow cytometric analysis of anti-CD30 CAR expression. 5e5 of anti-CD30 CAR-293 cells were stained with 100 μL of 2 μg/ml of AF 488-conjugated human CD30 Protein (Site-Specific AF 488 Conjugation, His Tag, Cat. No. 10777-H86H-SD) and negative control protein. Non-transduced 293 cells were used as a control (left) . AF 488 signal was used to evaluate the binding activity (QC tested) . 2.Binding activity of AF 488-conjugated CD30 protein to PBMC cells. PBMC cells were stained with PE conjugated anti-CD3 antibody and AF 488-conjugated human CD30 Protein (Site-Specific AF 488 Conjugation, His Tag, Cat. No. 10777-H86H-SD) and detected by flow cytometry. PE signal was used to evaluate the content of CD3+ T cells in PBMCs. AF 488 signal was used to evaluate the non-specific binding activity to PBMCs (QC tested) .

Met1-Lys379

The protein has a predicted molecular mass of 41.8 kDa.

Human